ND0612: A Multicenter, Randomized, Active-Controlled, Double-Blind, Double-Dummy, Parallel Group Clinical Trial, Investigating the Efficacy, Safety, and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects wit

Grants and Contracts Details

StatusActive
Effective start/end date12/3/1911/2/24

Funding

  • Syneos Health LLC: $100,029.00